Patent intelligence · US
US 8653055
Corticosteroid having low systemic absorption
Corticosteroid having low systemic absorption
Patent details — US 8653055
- Jurisdiction
- US
- Status
- granted
- Grant date
- Feb 18, 2014
- Expiration
- Feb 13, 2034
- Applicant
- Teva Animal Health, Inc.
- Claims
- 54
- CPC classes
- A61K, A61K47/26, A61K47/34, A61K9/0012
Quick answer
US 8653055 (Corticosteroid having low systemic absorption) is held by Teva Animal Health, Inc.. Status: granted. Granted Feb 18, 2014. Expires Feb 13, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Teva Animal Health, Inc.
- Grant date
- Expiration
- Claims
- 54
- CPC classes
- A61K, A61K47/26, A61K47/34, A61K9/0012, A61K9/0014, A61P
More from Teva Animal Health, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12310929
Use of rasagiline for the treatment of restless legs syndrome
granted -
US 12258401
Anti-CD47 combination therapy
granted -
US 12157729
Solid state forms of Belumosudil and Belumosudil salts
granted -
US 12139528
Treating refractory migraine
granted -
US 12091388
Solid state forms of Reproxalap
granted -
US 11826322
Pre-filled syringe
granted -
US 11813359
Sustained release olanzapine formulations
granted -
US 11773083
Solid state forms of Belumosudil and Belumosudil salts
granted
Frequently asked questions
What is US patent 8653055?
US 8653055 (Corticosteroid having low systemic absorption) is held by Teva Animal Health, Inc.. Status: granted. Granted Feb 18, 2014. Expires Feb 13, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8653055?
Teva Animal Health, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 454 pharmaceutical patents for this assignee.
When does US 8653055 expire?
Our index shows an expiration date of Feb 13, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.